Focus:
Mundipharma has signed an exclusive distribution agreement that will see Egis Pharmaceuticals introduce its Pelmeg drug in four Central and...
Ensure your company's deals are accurately presented to thousands of potential clients by using our deals submission form.
Total pharma industry deals for April 2019 worth $7.3bn were announced globally, according to GlobalData's deals database.
Total pharma industry venture financing deals in April 2019 worth $1.05bn were announced in the US, according to GlobalData's deals database.
North America's pharma industry saw a rise of 5.9% in deal activity during April 2019, when compared with the last 12-month average, according to GlobalData's deals database.
The US pharma industry saw a rise of 7.5% in overall deal activity during April 2019, when compared with the last 12-month average, according to GlobalData's deals database.
Total pharma industry M&A deals in April 2019 worth $4.1bn were announced globally, according to GlobalData's deals database.
Total pharma industry venture financing deals in April 2019 worth $1.55bn were announced globally, according to GlobalData's deals database.
Total pharma industry M&A deals in April 2019 worth $3.33bn were announced in the US, according to GlobalData's deals database.
JP Morgan was the leading financial adviser globally for mergers and acquisitions (M&A) in Q1 2019 in the healthcare sector, according to GlobalData.
Total pharma industry venture financing deals in Q1 2019 worth $4.93bn were announced globally, according to GlobalData's deals database.
Total pharma industry deals for March 2019 worth $9.75bn were announced globally, according to GlobalData's deals database.
Mundipharma has signed an exclusive distribution agreement that will see...
UK-based GlaxoSmithKline (GSK) has partnered with the University of California...
Synlogic has entered a platform collaboration with biotech company Ginkgo...
Genmab has signed a global licence and option agreement with...
Swedish Orphan Biovitrum (Sobi) has agreed to buy a newly...
US-based Deciphera Pharmaceuticals has signed an exclusive licence agreement with...
Boehringer Ingelheim has extended a collaboration with the University of...
Exscientia has entered a multi-target partnership with China-based GT Apeiron...
Merck has signed an agreement to buy biopharmaceutical company Tilos...
The US Federal Trade Commission (FTC) has requested that both...
Go Top
